The University of Chicago Header Logo

Connection

Christopher Shea to Melanoma

Back to Details
This is a "connection" page, showing publications Christopher Shea has written about Melanoma.
Christopher Shea
Connection Strength
4.928
Melanoma
  1. Grading Melanocytic Dysplasia: Updated Histopathologic Criteria. J Cutan Pathol. 2026 Jan; 53(1):29-37.
    View in: PubMed
    Score: 0.645
  2. Update on Thin Melanoma: Outcome of an International Workshop. Adv Anat Pathol. 2016 Jan; 23(1):24-9.
    View in: PubMed
    Score: 0.349
  3. Melanocytic tumors with intraepidermal melanophages: a report of five cases with review of 231 archived cutaneous melanocytic tumors. J Cutan Pathol. 2015 Jun; 42(6):394-9.
    View in: PubMed
    Score: 0.331
  4. Melanocytes, melanocyte stem cells, and melanoma stem cells. Clin Dermatol. 2013 Mar-Apr; 31(2):166-78.
    View in: PubMed
    Score: 0.287
  5. The recurrent nevus phenomenon: a history of challenge, controversy, and discovery. Arch Pathol Lab Med. 2011 Jul; 135(7):842-6.
    View in: PubMed
    Score: 0.255
  6. Immunohistochemistry of melanocytic proliferations. Arch Pathol Lab Med. 2011 Jul; 135(7):853-9.
    View in: PubMed
    Score: 0.255
  7. Shifts in Cutaneous Melanocytic Tumor Diagnostic Terminology: Melanocytoma, MPATH-Dx V2.0 and the WHO Skin5. J Cutan Pathol. 2026 Jan; 53(1):91-100.
    View in: PubMed
    Score: 0.166
  8. The Impact of Next-generation Sequencing on Interobserver Agreement and Diagnostic Accuracy of Desmoplastic Melanocytic Neoplasms. Am J Surg Pathol. 2024 Jun 01; 48(6):708-718.
    View in: PubMed
    Score: 0.155
  9. BRAF Mutated and Morphologically Spitzoid Tumors, a Subgroup of Melanocytic Neoplasms Difficult to Distinguish From True Spitz Neoplasms. Am J Surg Pathol. 2024 May 01; 48(5):538-545.
    View in: PubMed
    Score: 0.154
  10. Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions? Am J Clin Pathol. 2003 Aug; 120(2):203-8.
    View in: PubMed
    Score: 0.147
  11. Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions: A Consensus Statement. JAMA Netw Open. 2023 01 03; 6(1):e2250613.
    View in: PubMed
    Score: 0.142
  12. CD34 expression in desmoplastic melanoma. J Cutan Pathol. 2001 Nov; 28(10):508-12.
    View in: PubMed
    Score: 0.131
  13. Maturing papillomatous nevoid melanoma in the scalp mimicking recurrent melanocytic nevus: A case report of previously undescribed subtype of nevoid melanoma. Pathol Int. 2022 Jan; 72(1):59-64.
    View in: PubMed
    Score: 0.130
  14. Primary chondroid melanoma. J Cutan Pathol. 2001 Oct; 28(9):482-5.
    View in: PubMed
    Score: 0.130
  15. Malignant melanoma with paradoxical maturation. Am J Surg Pathol. 2000 Dec; 24(12):1600-14.
    View in: PubMed
    Score: 0.123
  16. Up-Regulation of PARP1 Expression Significantly Correlated with Poor Survival in Mucosal Melanomas. Cells. 2020 05 05; 9(5).
    View in: PubMed
    Score: 0.118
  17. Recent developments in the pathology of melanocytic neoplasia. Dermatol Clin. 1999 Jul; 17(3):615-30, ix.
    View in: PubMed
    Score: 0.111
  18. Prognostic role of tumoral PDL1 expression and peritumoral FoxP3+ lymphocytes in vulvar melanomas. Hum Pathol. 2018 03; 73:176-183.
    View in: PubMed
    Score: 0.100
  19. KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas. Br J Dermatol. 2017 Nov; 177(5):1376-1384.
    View in: PubMed
    Score: 0.099
  20. Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature. JAMA Dermatol. 2017 10 01; 153(10):999-1006.
    View in: PubMed
    Score: 0.098
  21. Scaly erythematous lesion in a patient with extensive solar damage. Malignant melanoma in situ, amelanotic type. Arch Dermatol. 1996 Oct; 132(10):1239, 1242.
    View in: PubMed
    Score: 0.092
  22. Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group. J Am Acad Dermatol. 2016 Aug; 75(2):356-63.
    View in: PubMed
    Score: 0.089
  23. Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma. J Cutan Pathol. 2015 Apr; 42(4):244-52.
    View in: PubMed
    Score: 0.083
  24. Angiotropic metastatic malignant melanoma. Am J Dermatopathol. 1995 Feb; 17(1):58-62.
    View in: PubMed
    Score: 0.082
  25. Nevus versus melanoma: to FISH, or not to FISH. Adv Anat Pathol. 2011 May; 18(3):229-34.
    View in: PubMed
    Score: 0.063
  26. Granulomatous eruption after BCG vaccine immunotherapy for malignant melanoma. J Am Acad Dermatol. 1989 Nov; 21(5 Pt 2):1119-22.
    View in: PubMed
    Score: 0.057
  27. Use of immunohistochemistry in melanocytic lesions. J Cutan Pathol. 2008 Nov; 35 Suppl 2:1-10.
    View in: PubMed
    Score: 0.053
  28. PAX3 expression in primary melanomas and nevi. Mod Pathol. 2008 May; 21(5):525-30.
    View in: PubMed
    Score: 0.051
  29. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus"). Am J Surg Pathol. 2008 Jan; 32(1):36-44.
    View in: PubMed
    Score: 0.050
  30. Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma. Br J Dermatol. 2006 Nov; 155(5):988-93.
    View in: PubMed
    Score: 0.046
  31. Angiotropism in epidermotropic metastatic melanoma: another clue to the diagnosis. Am J Dermatopathol. 2006 Oct; 28(5):429-33.
    View in: PubMed
    Score: 0.046
  32. Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901. J Immunother. 2006 Jan-Feb; 29(1):95-101.
    View in: PubMed
    Score: 0.044
  33. Pagetoid melanocytosis: when is it significant? Pathology. 2004 Oct; 36(5):435-44.
    View in: PubMed
    Score: 0.040
  34. Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases. Arch Dermatol. 2002 May; 138(5):603-8.
    View in: PubMed
    Score: 0.034
  35. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma. Am J Surg Pathol. 1999 Jul; 23(7):786-94.
    View in: PubMed
    Score: 0.028
  36. Primary malignant melanoma of the esophagus. J Surg Oncol. 1997 Nov; 66(3):201-6.
    View in: PubMed
    Score: 0.025
  37. Immunohistochemical expression of retinoblastoma protein in cutaneous melanomas. Br J Dermatol. 1995 Dec; 133(6):890-5.
    View in: PubMed
    Score: 0.022
  38. p53 expression is rare in cutaneous melanomas. Am J Dermatopathol. 1995 Aug; 17(4):344-9.
    View in: PubMed
    Score: 0.021
  39. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res. 1995 Jul 01; 55(13):2713-8.
    View in: PubMed
    Score: 0.021
  40. Immunohistochemical expression of BCL-2 in melanomas and intradermal nevi. J Cutan Pathol. 1994 Oct; 21(5):393-7.
    View in: PubMed
    Score: 0.020
  41. Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res. 1994 Feb; 4(1):35-45.
    View in: PubMed
    Score: 0.019
  42. Oncogenes in melanomas. J Dermatol. 1992 Nov; 19(11):853-67.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.